Produktname:N-(1-Carbamoylcyclohexyl)-4-chlorobenzamide
IUPAC Name:N-(1-carbamoylcyclohexyl)-4-chlorobenzamide
| Packungseinheit | Verfügbarer Vorrat | Preis($) | Menge |
|---|
| Product Overview |
N-(1-carbamoylcyclohexyl)-4-chlorobenzamide (NCCB) is a novel small molecule compound that has recently been developed as a potential therapeutic agent for the treatment of various diseases. NCCB is an amide compound that belongs to the family of carbamoylcyclohexyl derivatives. |
| Synthesis Method |
N-(1-carbamoylcyclohexyl)-4-chlorobenzamide can be synthesized through a two-step process. The first step involves the reaction of 4-chlorobenzoyl chloride with 1-cyclohexyl-1-carbamoylcyclopentane in the presence of a base catalyst. This reaction results in the formation of N-(1-carbamoylcyclohexyl)-4-chlorobenzamide. The second step involves the purification of the compound by recrystallization. The recrystallization process can be conducted in a variety of solvents such as ethanol, methanol, and ethyl acetate. |
| Chemical Properties |
N-(1-carbamoylcyclohexyl)-4-chlorobenzamide is relatively easy to synthesize and purify. It has been found to possess a number of biochemical and physiological effects that could be beneficial for laboratory experiments. |
| Synthesis and Application |
N-(1-carbamoylcyclohexyl)-4-chlorobenzamide has been found to possess anti-inflammatory and anticancer properties. In addition, N-(1-carbamoylcyclohexyl)-4-chlorobenzamide has been found to have neuroprotective effects and can be used to protect neurons from damage caused by oxidative stress and excitotoxicity. Furthermore, N-(1-carbamoylcyclohexyl)-4-chlorobenzamide has been studied for its potential use in the treatment of Alzheimer’s disease, Parkinson’s disease, and other neurological disorders. |
| Future Directions |
One potential direction is to further investigate the exact mechanism of action of N-(1-carbamoylcyclohexyl)-4-chlorobenzamide. In addition, further research could be conducted to explore the potential therapeutic effects of N-(1-carbamoylcyclohexyl)-4-chlorobenzamide in various diseases, such as cancer, inflammation, and neurological disorders. Furthermore, additional studies could be conducted to explore the potential use of N-(1-carbamoylcyclohexyl)-4-chlorobenzamide in the treatment of Alzheimer’s disease, Parkinson’s disease, and other neurological disorders. Finally, further research could be conducted to explore the potential use of N-(1-carbamoylcyclohexyl)-4-chlorobenzamide in the development of novel therapeutic agents. |
Suche 
+86 21 5895 0110 
